Clinical Trials
3 trialsNCT03259230 2024-09-19
Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis
Swedish Orphan Biovitrum
Completed
NCT03985423 2023-10-06
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH
Swedish Orphan Biovitrum
Phase 2/3 Terminated
NCT01818492 2023-02-21
Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis
Swedish Orphan Biovitrum
Phase 2/3 Completed